GLP-3 RT-10 is a novel investigational compound being studied in preclinical settings for its potential as a triple-receptor agonist targeting GLP-1, GIP,
GLP-3 RT-30 is a triple-receptor agonist compound targeting GLP-1, GIP, and glucagon receptors. Specifications: Unit Size: 30mg per vial Form: Lyophilized powder Storage: Store
